• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺特异性激肽释放酶相关肽酶及其与前列腺癌生物学和检测的关系。已确立的相关性和新出现的作用。

Prostate-specific kallikrein-related peptidases and their relation to prostate cancer biology and detection. Established relevance and emerging roles.

机构信息

Hans Lilja, MD, PhD, Memorial Sloan-Kettering Cancer Center, 1275 York Ave Box 213, New York, NY 10065, USA, Tel.: +1 212 639 6982, Fax: +1 646 422 2379, E-mail:

出版信息

Thromb Haemost. 2013 Sep;110(3):484-92. doi: 10.1160/TH13-04-0275. Epub 2013 Aug 1.

DOI:10.1160/TH13-04-0275
PMID:23903407
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4029064/
Abstract

Kallikreins are a family of serine proteases with a range of tissue-specific and essential proteolytic functions. Among the best studied are the prostate tissue-specific KLK2 and KLK3 genes and their secreted protease products, human kallikrein 2, hk2, and prostate-specific antigen (PSA). Members of the so-called classic kallikreins, these highly active trypsin-like serine proteases play established roles in human reproduction. Both hK2 and PSA expression is regulated by the androgen receptor which has a fundamental role in prostate tissue development and progression of disease. This feature, combined with the ability to sensitively detect different forms of these proteins in blood and biopsies, result in a crucially important biomarker for the presence and recurrence of cancer. Emerging evidence has begun to suggest a role for these kallikreins in critical vascular events. This review discusses the established and developing biological roles of hK2 and PSA, as well as the historical and advanced use of their detection to accurately and non-invasively detect and guide treatment of prostatic disease.

摘要

激肽释放酶是一族丝氨酸蛋白酶,具有多种组织特异性和重要的蛋白水解功能。其中研究得最多的是前列腺组织特异性 KLK2 和 KLK3 基因及其分泌的蛋白酶产物,人激肽释放酶 2(hk2)和前列腺特异性抗原(PSA)。这些所谓的经典激肽释放酶成员是高度活跃的胰蛋白酶样丝氨酸蛋白酶,在人类生殖中发挥着既定的作用。hK2 和 PSA 的表达均受雄激素受体调控,雄激素受体在前列腺组织发育和疾病进展中起着至关重要的作用。这一特征,加上能够在血液和活检中灵敏地检测到这些蛋白质的不同形式,使它们成为癌症存在和复发的重要生物标志物。新出现的证据开始表明这些激肽释放酶在关键的血管事件中发挥作用。本文讨论了 hK2 和 PSA 的既定和不断发展的生物学作用,以及它们的检测在准确和非侵入性地检测和指导前列腺疾病治疗方面的历史和先进应用。

相似文献

1
Prostate-specific kallikrein-related peptidases and their relation to prostate cancer biology and detection. Established relevance and emerging roles.前列腺特异性激肽释放酶相关肽酶及其与前列腺癌生物学和检测的关系。已确立的相关性和新出现的作用。
Thromb Haemost. 2013 Sep;110(3):484-92. doi: 10.1160/TH13-04-0275. Epub 2013 Aug 1.
2
Human kallikrein 2 (hK2), but not prostate-specific antigen (PSA), rapidly complexes with protease inhibitor 6 (PI-6) released from prostate carcinoma cells.人激肽释放酶2(hK2)而非前列腺特异性抗原(PSA)能迅速与前列腺癌细胞释放的蛋白酶抑制剂6(PI-6)结合形成复合物。
Int J Cancer. 2001 Nov;94(4):558-63. doi: 10.1002/ijc.1501.
3
Kallikreins as biomarkers for prostate cancer.激肽释放酶作为前列腺癌的生物标志物。
Biomed Res Int. 2014;2014:526341. doi: 10.1155/2014/526341. Epub 2014 Apr 7.
4
Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models.在人类前列腺癌模型中,雄激素对恶性生长的反应性与前列腺特异性分化标志物前列腺特异性抗原(PSA)、人激肽释放酶2(hK2)和前列腺特异性膜抗原(PSMA)表达之间的解离。
Prostate. 2003 Mar 1;54(4):249-57. doi: 10.1002/pros.10199.
5
Secretion of endogenous kallikreins 2 and 3 by androgen receptor-transfected PC-3 prostate cancer cells.雄激素受体转染的PC-3前列腺癌细胞分泌内源性激肽释放酶2和3 。
J Steroid Biochem Mol Biol. 2003 Apr;84(5):493-502. doi: 10.1016/s0960-0760(03)00069-4.
6
Decreased concentrations of prostate-specific antigen and human glandular kallikrein 2 in malignant versus nonmalignant prostatic tissue.恶性与非恶性前列腺组织中前列腺特异性抗原和人腺体激肽释放酶2浓度降低。
Urology. 2000 Sep 1;56(3):527-32. doi: 10.1016/s0090-4295(00)00621-x.
7
Enhancer RNAs participate in androgen receptor-driven looping that selectively enhances gene activation.增强子 RNA 参与雄激素受体驱动的环化,从而选择性地增强基因激活。
Proc Natl Acad Sci U S A. 2014 May 20;111(20):7319-24. doi: 10.1073/pnas.1324151111. Epub 2014 Apr 28.
8
Human Kallikrein 2 (hK2) and prostate-specific antigen (PSA): two closely related, but distinct, kallikreins in the prostate.人激肽释放酶2(hK2)和前列腺特异性抗原(PSA):前列腺中两种密切相关但又不同的激肽释放酶。
Crit Rev Clin Lab Sci. 1998 Aug;35(4):275-368. doi: 10.1080/10408369891234219.
9
Prostate-specific antigen (PSA) is activated by KLK2 in prostate cancer ex vivo models and in prostate-targeted PSA/KLK2 double transgenic mice.前列腺特异性抗原(PSA)在前列腺癌的体外模型和前列腺靶向 PSA/KLK2 双转基因小鼠中被 KLK2 激活。
Prostate. 2010 May 15;70(7):788-96. doi: 10.1002/pros.21111.
10
The tissue kallikrein family of serine proteases: functional roles in human disease and potential as clinical biomarkers.丝氨酸蛋白酶的组织激肽释放酶家族:在人类疾病中的功能作用及作为临床生物标志物的潜力
Crit Rev Clin Lab Sci. 2004;41(3):265-312. doi: 10.1080/10408360490471931.

引用本文的文献

1
A Phase 0 Study to Assess the Biodistribution and Pharmacokinetics of a Radiolabeled Antibody Targeting Human Kallikrein 2 in Participants with Metastatic Castration-Resistant Prostate Cancer.一项评估放射性标记的靶向人 Kallikrein 2 抗体在转移性去势抵抗性前列腺癌患者中的生物分布和药代动力学的 0 期研究。
J Nucl Med. 2024 Jul 1;65(7):1051-1056. doi: 10.2967/jnumed.124.267416.
2
Long-Term Exposure to Supraphysiological Levels of Testosterone Impacts Rat Submandibular Gland Proteome.长期暴露于超生理水平的睾酮会影响大鼠下颌下腺蛋白质组。
Int J Mol Sci. 2023 Dec 31;25(1):550. doi: 10.3390/ijms25010550.
3
Novel radionuclide therapy combinations in prostate cancer.前列腺癌中的新型放射性核素治疗组合
Ther Adv Med Oncol. 2023 Aug 2;15:17588359231187202. doi: 10.1177/17588359231187202. eCollection 2023.
4
Designed ankyrin repeat proteins for detecting prostate-specific antigen expression .设计用于检测前列腺特异性抗原表达的锚蛋白重复序列蛋白。
RSC Chem Biol. 2023 May 17;4(7):494-505. doi: 10.1039/d3cb00010a. eCollection 2023 Jul 5.
5
Single-cell analysis of human primary prostate cancer reveals the heterogeneity of tumor-associated epithelial cell states.单细胞分析人类原发性前列腺癌揭示了肿瘤相关上皮细胞状态的异质性。
Nat Commun. 2022 Jan 10;13(1):141. doi: 10.1038/s41467-021-27322-4.
6
Identification of Androgen Receptor Metabolic Correlome Reveals the Repression of Ceramide Kinase by Androgens.雄激素受体代谢相关组的鉴定揭示了雄激素对神经酰胺激酶的抑制作用。
Cancers (Basel). 2021 Aug 26;13(17):4307. doi: 10.3390/cancers13174307.
7
Prostate-specific antigen modulates the osteogenic differentiation of MSCs via the cadherin 11-Akt axis.前列腺特异性抗原通过钙黏蛋白11-Akt轴调节间充质干细胞的成骨分化。
Clin Transl Med. 2020 Jan;10(1):363-373. doi: 10.1002/ctm2.27.
8
Harnessing Androgen Receptor Pathway Activation for Targeted Alpha Particle Radioimmunotherapy of Breast Cancer.利用雄激素受体通路激活进行乳腺癌靶向 α 粒子放射免疫治疗。
Clin Cancer Res. 2019 Jan 15;25(2):881-891. doi: 10.1158/1078-0432.CCR-18-1521. Epub 2018 Sep 25.
9
Molecular Biomarkers in the Clinical Management of Prostate Cancer.**标题**: 前列腺癌临床管理中的分子生物标志物 **正文**: 前列腺癌是男性最常见的恶性肿瘤之一,其临床管理涉及多个方面,包括诊断、分期、治疗选择和预后评估。近年来,随着分子生物学技术的不断发展,越来越多的分子生物标志物被发现与前列腺癌的发生、发展和转移密切相关,为前列腺癌的临床管理提供了新的思路和策略。本文就前列腺癌临床管理中常用的分子生物标志物及其应用价值进行综述。
Cold Spring Harb Perspect Med. 2018 Nov 1;8(11):a030601. doi: 10.1101/cshperspect.a030601.
10
Tumour biomarkers: homeostasis as a novel prognostic indicator.肿瘤生物标志物:作为一种新型预后指标的内稳态
Open Biol. 2016 Dec;6(12). doi: 10.1098/rsob.160254.

本文引用的文献

1
Cancer statistics, 2013.癌症统计数据,2013 年。
CA Cancer J Clin. 2013 Jan;63(1):11-30. doi: 10.3322/caac.21166. Epub 2013 Jan 17.
2
Prostate cancer: ESMO Consensus Conference Guidelines 2012.前列腺癌:ESMO 共识会议指南 2012 年版。
Ann Oncol. 2013 May;24(5):1141-62. doi: 10.1093/annonc/mds624. Epub 2013 Jan 9.
3
Risk stratification in prostate cancer screening.前列腺癌筛查中的风险分层。
Nat Rev Urol. 2013 Jan;10(1):38-48. doi: 10.1038/nrurol.2012.225. Epub 2012 Dec 18.
4
Birth-and-death of KLK3 and KLK2 in primates: evolution driven by reproductive biology.KLK3 和 KLK2 在灵长类动物中的诞生和消亡:生殖生物学驱动的进化。
Genome Biol Evol. 2012;4(12):1331-8. doi: 10.1093/gbe/evs111.
5
Evaluation of [-2] proPSA and Prostate Health Index (phi) for the detection of prostate cancer: a systematic review and meta-analysis.游离前列腺特异性抗原 2 检测和前列腺健康指数(phi)在前列腺癌诊断中的应用:系统评价和荟萃分析。
Clin Chem Lab Med. 2013 Apr;51(4):729-39. doi: 10.1515/cclm-2012-0410.
6
Androgen receptor signaling in circulating tumor cells as a marker of hormonally responsive prostate cancer.循环肿瘤细胞中雄激素受体信号作为激素反应性前列腺癌的标志物。
Cancer Discov. 2012 Nov;2(11):995-1003. doi: 10.1158/2159-8290.CD-12-0222. Epub 2012 Oct 23.
7
Quality-of-life effects of prostate-specific antigen screening.前列腺特异性抗原筛查对生活质量的影响。
N Engl J Med. 2012 Aug 16;367(7):595-605. doi: 10.1056/NEJMoa1201637.
8
Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement.前列腺癌筛查:美国预防服务工作组推荐声明。
Ann Intern Med. 2012 Jul 17;157(2):120-34. doi: 10.7326/0003-4819-157-2-201207170-00459.
9
Screening for prostate cancer decreases the risk of developing metastatic disease: findings from the European Randomized Study of Screening for Prostate Cancer (ERSPC).前列腺癌筛查可降低发生转移性疾病的风险:来自前列腺癌筛查欧洲随机研究(ERSPC)的结果。
Eur Urol. 2012 Nov;62(5):745-52. doi: 10.1016/j.eururo.2012.05.068. Epub 2012 Jun 7.
10
Imaging androgen receptor signaling with a radiotracer targeting free prostate-specific antigen.使用靶向游离前列腺特异性抗原的放射性示踪剂对雄激素受体信号进行成像。
Cancer Discov. 2012 Apr;2(4):320-7. doi: 10.1158/2159-8290.CD-11-0316. Epub 2012 Mar 31.